Carla Nester

10.9k total citations · 1 hit paper
85 papers, 3.1k citations indexed

About

Carla Nester is a scholar working on Immunology, Nephrology and Hematology. According to data from OpenAlex, Carla Nester has authored 85 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 53 papers in Nephrology and 24 papers in Hematology. Recurrent topics in Carla Nester's work include Complement system in diseases (57 papers), Renal Diseases and Glomerulopathies (52 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). Carla Nester is often cited by papers focused on Complement system in diseases (57 papers), Renal Diseases and Glomerulopathies (52 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). Carla Nester collaborates with scholars based in United States, Spain and United Kingdom. Carla Nester's co-authors include James N. George, Richard J. Smith, Christie P. Thomas, Sanjeev Sethi, Nicole C. Meyer, Yuzhou Zhang, Santiago Rodrı́guez de Córdoba, Véronique Frémeaux‐Bacchi, Matthew C. Pickering and Peter F. Zipfel and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Carla Nester

70 papers receiving 3.1k citations

Hit Papers

Syndromes of Thrombotic M... 2014 2026 2018 2022 2014 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Carla Nester 2.5k 2.0k 948 471 373 85 3.1k
Tim Goodship 1.7k 0.7× 1.2k 0.6× 647 0.7× 296 0.6× 131 0.4× 47 2.2k
Max Solenthaler 2.0k 0.8× 990 0.5× 1.6k 1.7× 808 1.7× 87 0.2× 29 2.7k
Agnès Veyradier 2.4k 1.0× 1.3k 0.7× 1.8k 1.9× 962 2.0× 161 0.4× 108 3.3k
Michel Delahousse 1.1k 0.5× 1.3k 0.6× 255 0.3× 128 0.3× 355 1.0× 65 3.3k
Véronique Baudouin 467 0.2× 994 0.5× 317 0.3× 289 0.6× 244 0.7× 84 1.9k
Karim Kentouche 1.0k 0.4× 439 0.2× 801 0.8× 293 0.6× 119 0.3× 59 1.8k
Agnès Veyradier 1.5k 0.6× 741 0.4× 1.2k 1.2× 573 1.2× 91 0.2× 70 2.1k
Jean‐Claude Davin 670 0.3× 889 0.5× 210 0.2× 137 0.3× 477 1.3× 35 1.4k
Hernan Sabio 1.2k 0.5× 474 0.2× 1.0k 1.1× 449 1.0× 120 0.3× 55 2.2k
Charles F. Shield 404 0.2× 464 0.2× 352 0.4× 182 0.4× 316 0.8× 88 3.0k

Countries citing papers authored by Carla Nester

Since Specialization
Citations

This map shows the geographic impact of Carla Nester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Nester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Nester more than expected).

Fields of papers citing papers by Carla Nester

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Nester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Nester. The network helps show where Carla Nester may publish in the future.

Co-authorship network of co-authors of Carla Nester

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Nester. A scholar is included among the top collaborators of Carla Nester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Nester. Carla Nester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, Sarah M., Stuart S. Martin, Suzanne F. Cook, et al.. (2025). Detecting FH–anti-FH immune complexes in MGRS-C3G. Immunobiology. 230(4). 153044–153044.
2.
Smith, Richard, et al.. (2025). Assessing C3 nephritic factor function using Luminex-based formation and stabilization assays. Immunobiology. 230(4). 153038–153038.
3.
Nester, Carla, et al.. (2025). Antibodies in the healthy population influence convertase formation. Immunobiology. 230(4). 153025–153025.
4.
Gale, Daniel P., Andrew S. Bomback, Christoph Licht, et al.. (2025). #3391 Pegcetacoplan treatment appears to halt disease progression in C3G and primary (idiopathic) IC-MPGN patients: results from the phase 3 VALIANT study. Nephrology Dialysis Transplantation. 40(Supplement_3). 1 indexed citations
5.
Nester, Carla, Ute Eisenberger, Alexandre Karras, et al.. (2024). #277 Update to the long-term safety and efficacy of iptacopan in C3G: 33-month extension study data from patients enrolled in a phase 2 study. Nephrology Dialysis Transplantation. 39(Supplement_1).
6.
Nester, Carla, Richard J. Smith, David Kavanagh, et al.. (2024). Efficacy and Safety of Iptacopan in Patients with C3 Glomerulopathy: 12-Month Results from the Phase 3 APPEAR-C3G Study. Journal of the American Society of Nephrology. 35(10S). 1 indexed citations
8.
Nester, Carla, Ute Eisenberger, Alexandre Karras, et al.. (2024). Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy. Kidney International Reports. 10(2). 432–446. 2 indexed citations
9.
Taylor, Amanda, Nicole C. Meyer, Sarah M. Roberts, et al.. (2023). Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy. Kidney International Reports. 9(2). 464–477. 8 indexed citations
10.
Zhang, Yuzhou, et al.. (2023). Renin and renin blockade have no role in complement activity. Kidney International. 105(2). 328–337. 4 indexed citations
11.
Meyer, Nicole C., et al.. (2023). Modeling C3 glomerulopathies: C3 convertase regulation on an extracellular matrix surface. Frontiers in Immunology. 13. 2 indexed citations
12.
Nester, Carla, et al.. (2023). A Nef Precursor or Benign Counterpart: High Prevalence of Healthy Subjects with Antibody Reactivity to the C3-Convertase. Kidney360. 4(11). 1615–1622. 1 indexed citations
13.
Podos, Steven D., Howard Trachtman, Gerald B. Appel, et al.. (2022). Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan. American Journal of Nephrology. 53(10). 675–686. 11 indexed citations
14.
Zhang, Yuzhou, C. John Sperati, Kammi Henriksen, et al.. (2020). A Mutation in Complement Factor B Causing Massive Fluid-Phase Dysregulation of the Alternative Complement Pathway Can Result in Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology. 31(10S). 682–682.
15.
Bu, Fengxiao, Yuzhou Zhang, Kai Wang, et al.. (2018). Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology. 29(12). 2809–2819. 48 indexed citations
16.
Zhang, Yuzhou, Carla Nester, Mikkel‐Ole Skjoedt, et al.. (2014). Defining the Complement Biomarker Profile of C3 Glomerulopathy. Clinical Journal of the American Society of Nephrology. 9(11). 1876–1882. 66 indexed citations
17.
Bu, Fengxiao, Tara Maga, Nicole C. Meyer, et al.. (2013). Comprehensive Genetic Analysis of Complement and Coagulation Genes in Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology. 25(1). 55–64. 161 indexed citations
18.
Sethi, Sanjeev, Carla Nester, & Richard J. Smith. (2011). Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney International. 81(5). 434–441. 143 indexed citations
19.
Sethi, Sanjeev, Fernando C. Fervenza, Yuzhou Zhang, et al.. (2011). Proliferative Glomerulonephritis Secondary to Dysfunction of the Alternative Pathway of Complement. Clinical Journal of the American Society of Nephrology. 6(5). 1009–1017. 113 indexed citations
20.
Ammerman, Alice S., Michael Pignone, Kathleen N Lohr, et al.. (2001). Counseling to Promote a Healthy Diet. 181. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026